|
DUS4L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.50780532293516E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.76069994537198E-09 |
| Normal-vs-Stage2 |
8.857700E-03 |
| Normal-vs-Stage3 |
1.738370E-01 |
| Normal-vs-Stage4 |
8.021900E-02 |
| Stage1-vs-Stage2 |
7.070800E-01 |
| Stage1-vs-Stage3 |
2.489800E-02 |
| Stage1-vs-Stage4 |
7.827400E-01 |
| Stage2-vs-Stage3 |
7.042300E-02 |
| Stage2-vs-Stage4 |
9.968600E-01 |
| Stage3-vs-Stage4 |
2.070800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.24109669395057E-11 |
| Normal-vs-AfricanAmerican |
4.362600E-04 |
| Normal-vs-Asian |
3.807600E-01 |
| Caucasian-vs-AfricanAmerican |
2.768400E-01 |
| Caucasian-vs-Asian |
5.020000E-01 |
| AfricanAmerican-vs-Asian |
7.673200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.22900023491468E-10 |
| Normal-vs-Female |
1.83252999998995E-05 |
| Male-vs-Female |
5.142400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.599800E-03 |
| Normal-vs-Extreme_Weight |
8.08919999983893E-07 |
| Normal-vs-Obese |
1.88810999999234E-05 |
| Normal-vs-Extreme_Obese |
3.641800E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.892800E-01 |
| Normal_Weight-vs-Obese |
5.719000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.999000E-01 |
| Extreme_Weight-vs-Obese |
9.038200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.678600E-01 |
| Obese-vs-Extreme_Obese |
8.171400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.555380E-03 |
| Normal-vs-Age(41-60Yrs) |
2.98080005123325E-09 |
| Normal-vs-Age(61-80Yrs) |
9.02540000513596E-08 |
| Normal-vs-Age(81-100Yrs) |
2.282600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.735600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.791200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.617400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.075800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.826200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.630600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62470037423645E-12 |
| Normal-VS-Type2 PRCC |
1.872620E-01 |
| Normal-VS-KIRP CIMP |
2.058000E-01 |
| Normal-VS-Unclassified PRCC |
6.636600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.13560000081625E-08 |
| Type1 PRCC-VS-KIRP CIMP |
5.984100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.776330E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.903200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.053850E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.409600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.135880E-02 |
| Normal-vs-N1 |
3.964200E-02 |
| Normal-vs-N2 |
8.603600E-01 |
| N0-vs-N1 |
6.970200E-01 |
| N0-vs-N2 |
3.619200E-01 |
| N1-vs-N2 |
3.338400E-01 |
|
|
